Velarion Records

The 340B register and hospital finances — joined, watched daily, delivered.

SEC Form 4 · Rule 10b5-1 trading plans

Unity Biotechnology, Inc. (UBX)

In the 2025 filing year, Unity Biotechnology, Inc. filed 4 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 3 reporting owners, covering 4 transactions filed under those plans and 2,913 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 4 names a plan in a footnote. No results print is on file in this window, so no interval is measured.

Trades filed under a plan in Unity Biotechnology, Inc. 4

Plan adoption dates stated in Unity Biotechnology, Inc. 0

Quarterly results prints on file in Unity Biotechnology, Inc. 0

Trades in the days before a print in Unity Biotechnology, Inc. 0

Interval to the next reported results date

For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.

Order the document

Every company with plan records →

Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.